[Diabetic edematous maculopathy associated with rosiglitazone treatment: report of a case]

Nyssen, V.;Hautenauven, Frédéric;Lekeu Hinostroza, J.P.;Guagnini, Ann-Pascale
(2009) Bulletin de la Société belge d’ophtalmologie — n° 313, p. 39-44 (2009)

Files

No attached file found for this publication.

Details

Authors
  • Nyssen, V.UCLouvain
    Author
  • Hautenauven, FrédéricUCLouvain
    Author
  • Lekeu Hinostroza, J.P.UCLouvain
    Author
  • Author
Abstract
(en) A 61-year-old woman is referred for bilateral diabetic macular edema. Her visual acuity is 20/70 in the right eye and 20/50 in the left eye. She presents a macular edema on both eyes. Her diabetes and her blood pressure are well controlled. We note that the decrease in visual acuity occured when the patient began taking rosiglitazone (Avandia) 4 mg per day. Three months after replacing rosiglitazone by gliclazide (Diamicron), the visual acuity of the patient improves to 20/40 in the right eye and 20/30 in the left eye.
Affiliations

Citations

Nyssen, V., Hautenauven, F., Lekeu Hinostroza, J. P., & Guagnini, A.-P. (2009). [Diabetic edematous maculopathy associated with rosiglitazone treatment: report of a case]. Bulletin de la Société belge d’ophtalmologie, 313, 39-44. https://hdl.handle.net/2078.5/55774 (Original work published 2009)